Wechat

Website

Chinese Journal of Oncology Prevention and Treatment ›› 2011, Vol. 3 ›› Issue (2): 106-.doi: 10.3969/j.issn.1674-5671.2011.02.03

Previous Articles     Next Articles

YANG Ai-Qiong, WANG Chao-Li, LI Xue-Ting, XIE Yong-恩   

  • Online:2011-08-03 Published:2011-08-03

Abstract: 【Abstract】Objective To analyze the effect of bcl-xL down-regulation mediated by small interference RNA (siRNA) on the chemosensitivity of esophageal cancer cells to cisplatin and paclitaxel. Methods Three pairs of siRNA targeted at bcl-xL were designed and synthesized. Esophageal cancer cells were transfected with siRNA by using Lipofectamine 2000. bcl-xL expressions in the transfected cells and the control cells were determined by RT-PCR and Western blot. Cell proliferation inhibition rates of esophageal cancer cells treated with cisplatin and paclitaxel were detected by MTT assay. The IC50 values were calculated and compared. Results bcl-xL was down-regulated in esophageal cancer cells transfected with specific siRNA. The down-regulation of bcl-xL decreased the IC50 values of esophageal cancer cells treated with cisplatin or paclitaxel. Conclusion  the down-regulation of bcl-xL mediated by siRNA can increase the chemosensitivity of esophageal cancer cells to cisplatin and paclitaxel.

Key words: 【Key words】 bcl-xL, Small interference RNA, Chemosensitivity, Cisplatin, Paclitaxel